8月13日，新氧(SY)盘中上涨6.03%，截至23:35，报5.1美元/股，成交325.33万美元，总市值5.11亿美 元。 财务数据显示，截至2025年03月31日，新氧收入总额2.97亿人民币，同比减少6.6%；归母净利润-3313.8 万人民币，同比减少56.02%。 大事提醒： 8月15日，新氧将于(美东)盘前披露2025财年中报（数据来源于纳斯达克官网，预计披露日期为美国当 地时间，实际披露日期以公司公告为准）。 资料显示，新氧国际公司是一家致力于用科技的方式帮助爱美女性健康变美的公司。创始人成立了新 氧,通过提供透明的信息,改变中国快速增长但不透明的医学美学市场,最终使他们能够建立一个一站式的 平台,用户可以方便地找到优质的服务。 本文源自：金融界 作者：行情君 ...

Group 1 - The core viewpoint of the article highlights that Xinyang (SY) experienced a stock price increase of 2.08% on August 13, closing at $4.91 per share, with a total market capitalization of $492 million [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue amounted to 297 million RMB, reflecting a year-on-year decrease of 6.6%, while the net profit attributable to shareholders was -33.138 million RMB, a decline of 56.02% year-on-year [1] - Xinyang is set to disclose its fiscal year 2025 mid-term report on August 15, prior to the market opening in the Eastern Time Zone [2] Group 2 - Xinyang International Company focuses on leveraging technology to assist women in enhancing their health and beauty [2] - The founder established Xinyang to provide transparent information, aiming to transform the rapidly growing yet opaque medical aesthetics market in China [2] - The ultimate goal is to create a one-stop platform where users can conveniently find high-quality services [2]

Group 1 - The core viewpoint of the article highlights that Xinyang (SY) experienced a stock price increase of 5.54% on August 12, reaching $4.855 per share, with a total market capitalization of $487 million [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue was 297 million RMB, reflecting a year-on-year decrease of 6.6%, while the net profit attributable to the parent company was -33.138 million RMB, a decline of 56.02% year-on-year [1] Group 2 - A significant event reminder states that Xinyang is scheduled to disclose its fiscal year 2025 mid-term report on August 15, before the market opens in the Eastern Time zone [2] - Xinyang International Company is dedicated to leveraging technology to assist women in enhancing their health and beauty, aiming to transform the opaque medical aesthetics market in China into a transparent one, ultimately establishing a one-stop platform for users to easily find quality services [2]

Group 1 - The core viewpoint of the article highlights the recent stock performance of Xinyang (SY), which saw a 5.18% increase, reaching $5.08 per share, with a total market capitalization of $509 million as of August 9 [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue amounted to 297 million RMB, reflecting a year-on-year decrease of 6.6%, while the net profit attributable to the parent company was -33.138 million RMB, a significant decline of 56.02% year-on-year [1] Group 2 - A major event reminder states that Xinyang is scheduled to disclose its fiscal year 2025 mid-term report on August 15, prior to the market opening in the Eastern Time Zone [2] - Xinyang International Company is dedicated to leveraging technology to assist women in enhancing their health and beauty, aiming to transform the opaque medical aesthetics market in China by providing transparent information and establishing a one-stop platform for quality services [2]

8月7日，新氧(SY)盘中上涨5.07%，截至21:58，报5.18美元/股，成交83.84万美元，总市值5.19亿美元。 财务数据显示，截至2025年03月31日，新氧收入总额2.97亿人民币，同比减少6.6%；归母净利润-3313.8 万人民币，同比减少56.02%。 大事提醒： 8月15日，新氧将于(美东)盘前披露2025财年中报（数据来源于纳斯达克官网，预计披露日期为美国当 地时间，实际披露日期以公司公告为准）。 资料显示，新氧国际公司是一家致力于用科技的方式帮助爱美女性健康变美的公司。创始人成立了新 氧,通过提供透明的信息,改变中国快速增长但不透明的医学美学市场,最终使他们能够建立一个一站式的 平台,用户可以方便地找到优质的服务。 本文源自：金融界 作者：行情君 ...

8月7日，新氧(SY)开盘上涨2.03%，截至21:33，报5.03美元/股，成交12.16万美元，总市值5.04亿美元。 财务数据显示，截至2025年03月31日，新氧收入总额2.97亿人民币，同比减少6.6%；归母净利润-3313.8 万人民币，同比减少56.02%。 本文源自：金融界 作者：行情君 大事提醒： 8月15日，新氧将于(美东)盘前披露2025财年中报（数据来源于纳斯达克官网，预计披露日期为美国当 地时间，实际披露日期以公司公告为准）。 资料显示，新氧国际公司是一家致力于用科技的方式帮助爱美女性健康变美的公司。创始人成立了新 氧,通过提供透明的信息,改变中国快速增长但不透明的医学美学市场,最终使他们能够建立一个一站式的 平台,用户可以方便地找到优质的服务。 ...

Group 1 - The core viewpoint of the article highlights the recent performance of Xinyang (SY), which saw a stock price increase of 2.52% to $4.88 per share, with a total market capitalization of $489 million as of August 5 [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue was 297 million RMB, representing a year-on-year decrease of 6.6%, while the net profit attributable to the parent company was -33.138 million RMB, reflecting a significant year-on-year decline of 56.02% [1] - Xinyang is set to disclose its fiscal year 2025 mid-term report on August 15, prior to the market opening in the Eastern Time Zone [2] Group 2 - Xinyang International Company focuses on leveraging technology to assist women in enhancing their beauty and health, aiming to transform the opaque medical aesthetics market in China into a more transparent one [2] - The founder established Xinyang to provide transparent information, ultimately creating a one-stop platform for users to easily find quality services in the rapidly growing medical aesthetics sector [2]

8月15日，新氧将于(美东)盘前披露2025财年中报（数据来源于纳斯达克官网，预计披露日期为美国当 地时间，实际披露日期以公司公告为准）。 8月4日，新氧(SY)盘中上涨10.19%，截至23:06，报4.76美元/股，成交272.35万美元，总市值4.77亿美 元。 财务数据显示，截至2025年03月31日，新氧收入总额2.97亿人民币，同比减少6.6%；归母净利润-3313.8 万人民币，同比减少56.02%。 大事提醒： 资料显示，新氧国际公司是一家致力于用科技的方式帮助爱美女性健康变美的公司。创始人成立了新 氧,通过提供透明的信息,改变中国快速增长但不透明的医学美学市场,最终使他们能够建立一个一站式的 平台,用户可以方便地找到优质的服务。 本文源自金融界 ...

Group 1 - The stock price of Xinyang (SY) increased by 8.91% on August 4, closing at $4.705 per share, with a total trading volume of $1.2899 million and a market capitalization of $472 million [1] - As of March 31, 2025, Xinyang reported total revenue of 297 million RMB, a year-on-year decrease of 6.6%, and a net profit attributable to shareholders of -33.138 million RMB, representing a year-on-year decrease of 56.02% [1] Group 2 - Xinyang is scheduled to release its fiscal year 2025 mid-term report on August 15, before the market opens (Eastern Time) [2] - Xinyang International Company aims to leverage technology to assist women in enhancing their health and beauty, providing transparent information to transform the rapidly growing but opaque medical aesthetics market in China [2]

Investment Focus - The report highlights Amazon (AMZN US) as a top pick due to its leading position in the cloud industry with a 30% global market share, stable margin improvements, and strong demand for its T3 inference capabilities [1] - Alphabet (GOOGL US) is favored for its AI and advertising synergy, expected margin improvements in IaaS cloud services, and strong self-developed capabilities, although its stock price upside is currently limited [1] - Arista (ANET US) is recognized for its leadership in high-speed data center switches and expected revenue contributions from AI backend switch business, with a significant growth visibility [1] - Meituan (3690 HK) is noted for its strong cash flow generation ability and competitive cost structure, positioning it well in the face of industry competition [1] - Lenovo (992 HK) is highlighted for its record revenue in AI server business and significant growth potential compared to peers like Dell [2] - NVIDIA (NVDA US) is recognized for its strong financial performance and technological leadership in data center business, with a focus on emerging applications driving growth [2] - Tencent (700 HK) is expected to benefit significantly from AI advancements, with an upward revision in revenue and profit expectations for 2025 [2] - New Oriental (EDU US) is noted for its diverse revenue sources and strong brand recognition, supporting its high profit margins [3] - AIA (1299 HK) is favored for its steady growth in new business value and strong operational metrics, particularly in the ASEAN market [3] - Futu (FUTU US) is expected to see significant growth in paid user numbers and total AUM, supported by its low commission model and quality customer service [3] - The report emphasizes the potential of Chinese pharmaceutical companies like China Biologic Products (1177 HK) and Innovent Biologics (1801 HK) in their innovative drug pipelines and market leadership [4]